Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity.

Elkashef A, Rawson RA, Smith E, Pearce V, Flammino F, Campbell J, Donovick R, Gorodetzky C, Haning W, Mawhinney J, McCann M, Weis D, Williams L, Ling W, Vocci F.

Addiction. 2007 Apr;102 Suppl 1:107-13.

PMID:
17493059
2.

Treatment of methamphetamine use disorders: an update.

Rawson RA, Gonzales R, Brethen P.

J Subst Abuse Treat. 2002 Sep;23(2):145-50. Review.

PMID:
12220612
3.

Treatment of methamphetamine abuse: research findings and clinical directions.

Cretzmeyer M, Sarrazin MV, Huber DL, Block RI, Hall JA.

J Subst Abuse Treat. 2003 Apr;24(3):267-77. Review.

PMID:
12810148
4.
5.
7.

Treatments for methamphetamine abuse: a literature review for the clinician.

Brackins T, Brahm NC, Kissack JC.

J Pharm Pract. 2011 Dec;24(6):541-50. doi: 10.1177/0897190011426557. Epub 2011 Nov 17. Review.

PMID:
22095579
8.

The epidemiology of methamphetamine use and harm in Australia.

Degenhardt L, Roxburgh A, Black E, Bruno R, Campbell G, Kinner S, Fetherston J.

Drug Alcohol Rev. 2008 May;27(3):243-52. doi: 10.1080/09595230801950572. Review.

PMID:
18368605
9.

Approaches to the development of medications for the treatment of methamphetamine dependence.

Vocci FJ, Appel NM.

Addiction. 2007 Apr;102 Suppl 1:96-106. Review.

PMID:
17493058
10.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

11.

Methamphetamine abuse.

Winslow BT, Voorhees KI, Pehl KA.

Am Fam Physician. 2007 Oct 15;76(8):1169-74. Review.

12.
13.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
14.

Epidemiology of methamphetamine abuse in Missouri.

Topolski JM.

Mo Med. 2007 Jan-Feb;104(1):82-8. Review.

PMID:
17410832
15.

Corticolimbic dysregulation and chronic methamphetamine abuse.

Baicy K, London ED.

Addiction. 2007 Apr;102 Suppl 1:5-15. Review.

PMID:
17493049
16.

Incorporating brain research findings into standard treatment: an example using the Matrix Model.

Obert JL, London ED, Rawson RA.

J Subst Abuse Treat. 2002 Sep;23(2):107-13. Review.

PMID:
12220608
17.

Pharmacotherapy of amphetamine-type stimulant dependence: an update.

Brensilver M, Heinzerling KG, Shoptaw S.

Drug Alcohol Rev. 2013 Sep;32(5):449-60. doi: 10.1111/dar.12048. Epub 2013 Apr 25. Review.

18.

Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature.

Courtney KE, Ray LA.

Drug Alcohol Depend. 2014 Oct 1;143:11-21. doi: 10.1016/j.drugalcdep.2014.08.003. Epub 2014 Aug 17. Review.

19.

'Tweaking 12-Step': the potential role of 12-Step self-help group involvement in methamphetamine recovery.

Donovan DM, Wells EA.

Addiction. 2007 Apr;102 Suppl 1:121-9. Review.

PMID:
17493061
20.

Amphetamines: an update on forensic issues.

Logan BK.

J Anal Toxicol. 2001 Jul-Aug;25(5):400-4. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk